Zytiga is a drug used in the treatment of prostate cancer whose active substance is abiraterone acetate.Abiraterone inhibits a substance necessary for the production of hormones that regulate male characteristics, but are also linked to increased cancer, so this drug prevents progression.tumor in the prostate, thus increasing life expectancy.
Although Zytiga abiraterone causes the adrenal glands to produce more natural corticosteroids, it is common for your doctor to also recommend corticosteroids together, to help reduce prostate inflammation and improve symptoms, such as difficulty urinating or feeling full bladder, for example.
- This drug is available in 250 mg tablets and has an average price of 10 to 15.
- 000 reais per pack.
- But is also included in the SUS Drug LIST.
Zytiga is indicated for the treatment of prostate cancer in adult men when the cancer spreads throughout the body.It can also be used in men who have not improved their disease after castration to suppress sex hormone production or after docetaxel chemotherapy.
How using Zytiga involves taking 4 250 mg tablets in one shot, approximately 2 hours after a meal.Food should not be eaten for at least 1 hour after use.Do not exceed the maximum daily dose of 1000 mg.
Zytiga is also usually taken in combination with 5 or 10 mg of prednisone or prednisolone, twice daily, according to the doctor’s advice.
Using this medicine may cause certain side effects, the most common may include:
There may also be a reduction in potassium levels in the body, resulting in muscle weakness, cramps and heart palpitations.
Generally, this medicine is used under the supervision of a doctor or health care professional, such as a nurse, who will be alert to any of these effects, initiating appropriate treatment, if necessary.
Zytiga is contraindicated in people with hypersensitivity to abiraterone or any of the components of the formula, as well as in patients with severe hepatic impairment.It should not be used in pregnant or lactating women.